Andrew E. Schade
Impact in
- Hematology top 5%
- Chronic Myeloid Leukemia Treatments
- Genetics top 5%
- Chronic Lymphocytic Leukemia Research
Papers in
-
- Angiogenesis and VEGF in Cancer 5
- Immunology 14
- Immunodeficiency and Autoimmune Disorders 4
- Complement system in diseases 4
- T-cell and B-cell Immunology 4
- Immune Cell Function and Interaction 4
- Co-authors
- Alan D. Levine (4 shared papers)Jaroslaw P. Maciejewski (11 shared papers)Marcin W. Włodarski (4 shared papers)Hadrian Szpurka (6 shared papers)Anna Jankowska (2 shared papers)Gary L. Schieven (1 shared paper)Rosemary Zhang (1 shared paper)Vojkan Susulic (1 shared paper)
- Journals
- Blood (9 papers)Cancer Research (4 papers)The Journal of Immunology (3 papers)Journal of Clinical Oncology (2 papers)Laboratory Investigation (2 papers)
- Partner nations
- United StatesSwedenAustralia
In The Last Decade
Andrew E. Schade
50 papers receiving 1.1k citations
Andrew E. Schade's Hit Papers
Peers
Comparison fields: 5 of 92
- Hematology 214
- Genetics 184
- Immunology 324
- Oncology 199
- Pathology and Forensic Medicine 90
Countries citing papers authored by Andrew E. Schade
This map shows the geographic impact of Andrew E. Schade's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew E. Schade with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew E. Schade more than expected).
Fields of papers citing papers by Andrew E. Schade
This network shows the impact of papers produced by Andrew E. Schade. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew E. Schade. The network helps show where Andrew E. Schade may publish in the future.
Co-authors
The 25 scholars most cited alongside Andrew E. Schade, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 51 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 227 | |
| 2 | Association of Donanemab Treatment With Exploratory Plasma Biomarkers in Early Symptomatic Alzheimer Disease Hit paper breakdown → | 2022 | 147 |
| 3 | 2002 | 114 | |
| 4 | 2012 | 77 | |
| 5 | 2006 | 67 | |
| 6 | 2019 | 63 | |
| 7 | 2013 | 40 | |
| 8 | 2006 | 37 | |
| 9 | 2004 | 33 | |
| 10 | 2009 | 32 | |
| 11 | Ischemic time impacts biological integrity of phospho-proteins in PI3K/Akt, Erk/MAPK, and p38 MAPK signaling networks. | 2011 | 30 |
| 12 | 2017 | 26 | |
| 13 | 2006 | 26 | |
| 14 | 2020 | 22 | |
| 15 | 1997 | 22 | |
| 16 | 2020 | 20 | |
| 17 | 2008 | 16 | |
| 18 | Heterogeneity of Vascular Endothelial Growth Factor Receptors 1, 2, 3 in Primary Human Colorectal Carcinoma. | 2016 | 15 |
| 19 | 2016 | 11 | |
| 20 | 2008 | 11 |
About Andrew E. Schade
Andrew E. Schade is a scholar working on Molecular Biology, Immunology, Hematology, Genetics and Oncology, having authored 51 papers that have together received 1.1k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (6 papers), Angiogenesis and VEGF in Cancer (5 papers), Immunodeficiency and Autoimmune Disorders (4 papers), Complement system in diseases (4 papers), T-cell and B-cell Immunology (4 papers), Immune Cell Function and Interaction (4 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Computational Drug Discovery Methods (3 papers). The work is most often cited by research in Hematology (214 citations), Genetics (184 citations), Immunology (324 citations), Oncology (199 citations) and Pathology and Forensic Medicine (90 citations). Andrew E. Schade has collaborated with scholars based in United States, Sweden and Australia. Frequent co-authors include Alan D. Levine, Jaroslaw P. Maciejewski, Marcin W. Włodarski, Hadrian Szpurka, Anna Jankowska, Gary L. Schieven, Rosemary Zhang, Vojkan Susulic, Robert Townsend and Timothy R. Holzer. Their work appears in journals such as Blood, Cancer Research, The Journal of Immunology, Journal of Clinical Oncology and Laboratory Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.